State Claims Too Late For GSK, Teva Lamictal Antitrust Row
A New Jersey federal judge on Tuesday tossed state-law claims brought by indirect purchasers of GlaxoSmithKline's epilepsy drug Lamictal in a pay-for-delay suit over a settlement with Teva Pharmaceutical, concluding that...To view the full article, register now.
Already a subscriber? Click here to view full article